0001209191-21-023107.txt : 20210325
0001209191-21-023107.hdr.sgml : 20210325
20210325203225
ACCESSION NUMBER: 0001209191-21-023107
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210323
FILED AS OF DATE: 20210325
DATE AS OF CHANGE: 20210325
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kosaraju Sridhar
CENTRAL INDEX KEY: 0001651325
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39035
FILM NUMBER: 21774282
MAIL ADDRESS:
STREET 1: 1351 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 10x Genomics, Inc.
CENTRAL INDEX KEY: 0001770787
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 455614458
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6230 STONERIDGE MALL ROAD
CITY: PLEASANTON
STATE: CA
ZIP: 94588
BUSINESS PHONE: (925) 401-7300
MAIL ADDRESS:
STREET 1: 6230 STONERIDGE MALL ROAD
CITY: PLEASANTON
STATE: CA
ZIP: 94588
FORMER COMPANY:
FORMER CONFORMED NAME: 10X Genomics, Inc.
DATE OF NAME CHANGE: 20190315
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-23
0
0001770787
10x Genomics, Inc.
TXG
0001651325
Kosaraju Sridhar
C/O 10X GENOMICS, INC.
6230 STONERIDGE MALL ROAD
PLEASANTON
CA
94588
1
0
0
0
Class A Common Stock
2021-01-25
5
G
0
E
7167
0.00
D
2833
D
Class A Common Stock
2021-01-25
5
G
0
E
7167
0.00
A
18000
I
See Footnote
Class A Common Stock
2021-03-23
4
S
0
1200
173.9625
D
16800
I
See Footnote
Class A Common Stock
2021-03-23
4
S
0
100
175.71
D
16700
I
See Footnote
Class A Common Stock
2021-03-23
4
S
0
200
178.065
D
16500
I
See Footnote
These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust").
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust.
This transaction was executed in multiple trades at prices ranging from $173.48 to $174.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $177.76 to $178.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
/s/ Eric S. Whitaker, as Attorney-in-Fact
2021-03-25